XML 24 R13.htm IDEA: XBRL DOCUMENT v3.25.2
Common Stock
3 Months Ended
Aug. 31, 2025
Common Stock [Abstract]  
Common Stock

NOTE 7. Common Stock

 

The Company’s Class A ordinary shares and public warrants trade on the Nasdaq Capital Market under the symbol “HOVR” and “HOVRW”, respectively. Pursuant to the terms of the Company’s Articles and Notice of Articles, the Company is authorized to issue the following shares and classes of capital stock, each with no par value: (i) an unlimited number of Class A ordinary shares; (ii) an unlimited number of Class B ordinary shares; and (iii) an unlimited number of preferred shares. The holder of each ordinary share is entitled to one vote.

   

As of August 31, 2025, there were warrants outstanding of 12,065,375 at an exercise price of $11.50 USD and 310,000 at an exercise price of $0.75 USD to purchase an equivalent number of Class A ordinary shares.

 

Warrant holders exercised 2,900,000 warrants in exchange for 2,900,000 Class A ordinary shares for proceeds of $2,970 during the three months-ended August 31, 2025.

 

A summary of warrant activity for the Company is as follows:

 

   Number of Warrants   Weighted Average Exercise
Price(USD)
   Weighted
Average
Remaining
Contractual Life
(years)
   Aggregate
Intrinsic
Value
(USD)
 
Outstanding warrants May 31, 2025   15,275,375   $9.24    3.7   $995 
Exercised   2,900,000   $0.75    4.0    3,065 
Outstanding warrants August 31, 2025   12,375,375   $11.23    3.7   $310 

In March 2025 the Company filed a shelf registration statement on Form S-3 with the SEC and a related prospectus pursuant to which it may, from time to time, sell shares of its Class A ordinary shares, having an aggregate value of up to $6.25 million USD, pursuant to a Capital on Demand™ Sales Agreement (the “Sales Agreement”) with a placement agent for the sale of its Class A ordinary shares.

 

On June 27, 2025, the Company filed a prospectus supplement to increase the maximum aggregate offering price of the Class A ordinary shares issuable under the Sales Agreement to up to an additional aggregate $16.5 million USD of Class A ordinary shares. 

 

During the three months-ended August 31, 2025, the Company sold 3,445,210 shares of Class A ordinary shares under the Sales Agreement for net proceeds of $8,253. As of August 31, 2025, the Company had $14.8 million USD remaining eligible for sales under the Sales Agreement.

 

During the three months-ended August 31, 2025, the Company incurred $410 in general and administrative costs relating to 264,095 of Class A ordinary shares to be issued at a future date for services rendered. This has been recorded as a component of Shareholders’ Equity.